SCHEMBL6829264

SCHEMBL6829264

Cc1c(Cl)cccc1S(=O)(=O)Nc1nc(CCCC(C)C)ns1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 10/20 0.46
HSD17B1 P14061 2/20 0.44
HSD17B2 P37059 2/20 0.44
SLC40A1 Q9NP59 1/20 0.43
EDNRB P24530 2/20 0.42
EDNRA P25101 2/20 0.42
CCR4 P51679 2/20 0.41
HTR6 P50406 1/20 0.38
HTT P42858 1/20 0.37
NR3C1 P04150 1/20 0.36
AKT1 P31749 1/20 0.35
MYLK Q15746 1/20 0.35
MAPK14 Q16539 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5392563 0.87 HSD11B1 (0.50) HSD11B1HSD17B1HSD17B2SLC40A1EDNRB
SCHEMBL5830655 0.85 HSD11B1 (0.50) HSD11B1HSD17B1HSD17B2SLC40A1EDNRB
SCHEMBL5831586 0.85 HSD11B1 (0.50) HSD11B1HSD17B1HSD17B2SLC40A1EDNRB
SCHEMBL5830922 0.84 HSD11B1 (0.46) HSD11B1HSD17B1HSD17B2SLC40A1EDNRB
SCHEMBL6623269 0.84 HSD11B1 (0.45) HSD11B1HSD17B1HSD17B2SLC40A1EDNRB
SCHEMBL5404821 0.83 HSD11B1 (0.53) HSD11B1HSD17B1HSD17B2SLC40A1EDNRB
SCHEMBL5830828 0.83 HSD11B1 (0.48) HSD11B1HSD17B1HSD17B2SLC40A1EDNRB
SCHEMBL5831440 0.82 HSD11B1 (0.47) HSD11B1HSD17B1HSD17B2SLC40A1EDNRB
SCHEMBL5831031 0.82 HSD11B1 (0.47) HSD11B1HSD17B1HSD17B2SLC40A1EDNRB
SCHEMBL5831141 0.82 HSD11B1 (0.46) HSD11B1HSD17B1HSD17B2SLC40A1EDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004113310-A1 USE OF AN INHIBITOR OF 11-B-HYDROXYSTEROID DEHYDROGENASE TYPE 1 COMPOUNDS FOR PROMOTING WOUND HEALING BIOVITRUM AB (SE) 2004-12-29 WO disclosed